Related references
Note: Only part of the references are listed.New Perspectives in the Pharmacological Potential of Naringin in Medicine
Maria Angelica Rivoira et al.
CURRENT MEDICINAL CHEMISTRY (2021)
The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets
Julie K. Nguyen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2020)
Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation
Stuart A. Cook et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Albumin self-modified liposomes for hepatic fibrosis therapy via SPARC-dependent pathways
Jianzhu Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Non-canonical (non-SMAD2/3) TGF-β signaling in fibrosis: Mechanisms and targets
Kenneth W. Finnson et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2020)
Naringenin mitigates autoimmune features in lupus-prone mice by modulation of T-cell subsets and cytokines profile
Amayrani Abrego-Peredo et al.
PLOS ONE (2020)
Naringenin loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in hepatic fibrosis
Fan Yang et al.
BIOMEDICAL MICRODEVICES (2020)
Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy againstCOVID-19
Helda Tutunchi et al.
PHYTOTHERAPY RESEARCH (2020)
Fibrosis: from mechanisms to medicines
Neil C. Henderson et al.
NATURE (2020)
Naringenin and naringin in cardiovascular disease prevention: A preclinical review
Reza Heidary Moghaddam et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Cellular and molecular mechanisms of kidney fibrosis
Sonja Djudjaj et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Ralf Weiskirchen et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
Efficient biosynthesis, analysis, solubility and anti-bacterial activities of succinylglycosylated naringenin
S. Zhang et al.
NATURAL PRODUCT RESEARCH (2019)
The Smad3-miR-29b/miR-29c axis mediates the protective effect of macrophage migration inhibitory factor against cardiac fibrosis
Jing-nan Liang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Shared and distinct mechanisms of fibrosis
Joerg H. W. Distler et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus
Allan Henrique Depieri Cataneo et al.
SCIENTIFIC REPORTS (2019)
Naringenin attenuates the progression of liver fibrosis via inactivation of hepatic stellate cells and profibrogenic pathways
Erika Hernandez-Aquino et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Naringenin Ameliorates Renovascular Hypertensive Renal Damage by Normalizing the Balance of Renin-Angiotensin System Components in Rats
Zhizhi Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
New insights into TGF-β/Smad signaling in tissue fibrosis
He-He Hu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Involvement of Smad3 pathway in atrial fibrosis induced by elevated hydrostatic pressure
Wei Wei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Naringenin Ameliorates Radiation-Induced Lung Injury by Lowering IL-1β Level
Chao Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
The Protective Effect of Naringenin on Airway Remodeling after Mycoplasma Pneumoniae Infection by Inhibiting Autophagy-Mediated Lung Inflammation and Fibrosis
Yan Lin et al.
MEDIATORS OF INFLAMMATION (2018)
Combating oxidative stress disorders with citrus flavonoid: Naringenin
Nurul Hannim Zaidun et al.
LIFE SCIENCES (2018)
Naringenin as a potential immunomodulator in therapeutics
Wenfeng Zeng et al.
PHARMACOLOGICAL RESEARCH (2018)
Natural Products as a Source for Antifibrosis Therapy
Dan-Qian Chen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update
Ruthvika Joshi et al.
LIFE SCIENCES (2018)
Protective Effects of Five Structurally Diverse Flavonoid Subgroups against Chronic Alcohol-Induced Hepatic Damage in a Mouse Model
Liang Zhao et al.
NUTRIENTS (2018)
Endothelial-Derived Endothelin-1 Promotes Pulmonary Vascular Remodeling in Bleomycin-Induced Pulmonary Fibrosis
A. B. Hartopo et al.
PHYSIOLOGICAL RESEARCH (2018)
Toll-like receptors in the pathogenesis of pulmonary fibrosis
Theodoros Karampitsakos et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Signalling pathways involved in hypoxia-induced renal fibrosis
Minna Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
Naringenin attenuates fibroblast activation and inflammatory response in a mechanical stretch-induced hypertrophic scar mouse model
Shengzhou Shan et al.
MOLECULAR MEDICINE REPORTS (2017)
The ascending rank of chronic kidney disease in the global burden of disease study
Kitty J. Jager et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2017)
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
Erika Hernandez-Aquino et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Toll-Like Receptor 4-Independent Carbon Tetrachloride-Induced Fibrosis and Lipopolysaccharide-Induced Acute Liver Injury in Mice Role of Hepatic Stellate Cells
Sudhir Kumar et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Treatment of Renal Fibrosis-Turning Challenges into Opportunities
Barbara M. Klinkhammer et al.
ADVANCES IN CHRONIC KIDNEY DISEASE (2017)
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration
Virpi Talman et al.
CELL AND TISSUE RESEARCH (2016)
Versican: a novel modulator of hepatic fibrosis
Terence N. Bukong et al.
LABORATORY INVESTIGATION (2016)
TGF-β: the master regulator of fibrosis
Xiao-ming Meng et al.
NATURE REVIEWS NEPHROLOGY (2016)
Naringenin inhibits proliferation, migration, and invasion as well as induces apoptosis of gastric cancer SGC7901 cell line by downregulation of AKT pathway
Lei Bao et al.
TUMOR BIOLOGY (2016)
Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy
Ning Yan et al.
JOURNAL OF DIABETES RESEARCH (2016)
Endothelial to Mesenchymal Transition (EndoMT) in the Pathogenesis of Human Fibrotic Diseases
Sonsoles Piera-Velazquez et al.
JOURNAL OF CLINICAL MEDICINE (2016)
High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism
Naiara Orrego-Lagaron et al.
BRITISH JOURNAL OF NUTRITION (2015)
Naringenin and Atherosclerosis: A Review of Literature
Ilkay E. Orhan et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway
Yassine Chtourou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Naringenin improves learning and memory in an Alzheimer's disease rat model: Insights into the underlying mechanisms
Saeed Ghofrani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation
Vengadeshprabhu Karuppagounder et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Fibrosis - A Common Pathway to Organ Injury and Failure
Don C. Rockey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effects of the Flavanone combination Hesperetin-Naringenin, and Orange and Grapefruit Juices, on Airway inflammation and Remodeling in a murine asthma model
Ensiyeh Seyedrezazadeh et al.
PHYTOTHERAPY RESEARCH (2015)
Naringenin attenuates pressure overload-induced cardiac hypertrophy
Ning Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)
Reversibility of liver fibrosis
Mengxi Sun et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
Xiao-ming Meng et al.
ONCOTARGET (2015)
Modulation of angiotensin II signaling in the prevention of fibrosis
Amanda M. Murphy et al.
FIBROGENESIS & TISSUE REPAIR (2015)
Myofibroblast Differentiation: Main Features, Biomedical Relevance, and the Role of Reactive Oxygen Species
Alessandro Siani et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Naringenin attenuates CCl4-induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats
Mohammad Ali Esmaeili et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2014)
Potential Roles of BMP9 in Liver Fibrosis
Jianjun Bi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Naringenin inhibits allergen-induced airway remodeling in a murine model of asthma
Ying Shi et al.
MOLECULAR MEDICINE REPORTS (2014)
Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway
Haiyan Lou et al.
NEUROPHARMACOLOGY (2014)
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
Talmadge E. King et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Tumor Growth Attenuating Effects of Naringenin
Shailendra Kapoor
PATHOLOGY & ONCOLOGY RESEARCH (2014)
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Gulsum Ozlem Elpek
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
EGFR signaling in renal fibrosis
Shougang Zhuang et al.
KIDNEY INTERNATIONAL SUPPLEMENTS (2014)
Strategies for anti-fibrotic therapies
Joel Rosenbloom et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
The pathogenesis of pulmonary fibrosis: a moving target
Wim A. Wuyts et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Molecular basis of organ fibrosis: Potential therapeutic approaches
Asish K. Ghosh et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Antimicrobial Effect of 7-O-Butylnaringenin, a Novel Flavonoid, and Various Natural Flavonoids against Helicobacter pylori Strains
Sun Hee Moon et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2013)
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis
Angelika Horn et al.
ARTHRITIS AND RHEUMATISM (2012)
Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
Jun Wei et al.
ARTHRITIS AND RHEUMATISM (2012)
Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats
T. Annadurai et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2012)
Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics Part II. Strategies to reduce scar formation after dermatologic procedures
Christos Tziotzios et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Targeting the TGFβ signalling pathway in disease
Rosemary J. Akhurst et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Anti-inflammatory role of naringenin in rats with ethanol induced liver injury
Jayachitra Jayaraman et al.
TOXICOLOGY MECHANISMS AND METHODS (2012)
Naringinases: occurrence, characteristics, and applications
Maria H. Ribeiro
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Scraping fibrosis
Wajahat Z. Mehal et al.
NATURE MEDICINE (2011)
Recommendations on clinical proof of efficacy for potential scar prevention and reduction therapies
James A. Bush et al.
WOUND REPAIR AND REGENERATION (2011)
Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis
Benjamin D. Humphreys et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethane-treated rats
Tety Leonardi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2010)
Oxidative stress, extracellular matrix targets, and idiopathic pulmonary fibrosis
Corrine R. Kliment et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity
Jayachitra Jayaraman et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a comparative study
Monica Cavia-Saiz et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2010)
Evolving challenges in hepatic fibrosis
Scott L. Friedman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Pathophysiological Consequences of HIF Activation HIF as a Modulator of Fibrosis
Volker H. Haase
HYPOXIA AND CONSEQUENCES FROM MOLECULE TO MALADY (2009)
Pivotal Role of Connective Tissue Growth Factor in Lung Fibrosis MAPK-Dependent Transcriptional Activation of Type I Collagen
Markella Ponticos et al.
ARTHRITIS AND RHEUMATISM (2009)
Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappa B activity in a murine model of asthma
Ying Shi et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
Naringenin: A Potential Immunomodulator for Inhibiting Lung Fibrosis and Metastasis
Gangjun Du et al.
CANCER RESEARCH (2009)
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
Young-Suk Lim et al.
CLINICS IN LIVER DISEASE (2008)
Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis
Xu Shi-Wen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation
R. R. Ortiz-Andrade et al.
DIABETES OBESITY & METABOLISM (2008)
Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin
Yaakov Nahmias et al.
HEPATOLOGY (2008)
Hepatoprotective effect of infliximab, an anti-TNF-α agent, on carbon tetrachloride-induced hepatic fibrosis
Ibrahim Halil Bahcecioglu et al.
INFLAMMATION (2008)
Cellular and molecular mechanisms of fibrosis
T. A. Wynn
JOURNAL OF PATHOLOGY (2008)
The hidden cost of skin scars: quality of life after skin scarring
B. C. Brown et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2008)
Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation
Brett Burstein et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Flavonoid composition of citrus juices
Giuseppe Gattuso et al.
MOLECULES (2007)
The myofibroblast - One function, multiple origins
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
.Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects
F. I. Kanaze et al.
EUROPEAN JOURNAL OF CLINICAL NUTRITION (2007)
Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-kappa B activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-kappa B activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages
Mari Hamalainen et al.
MEDIATORS OF INFLAMMATION (2007)
Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats
Seon-Min Jeon et al.
TRANSLATIONAL RESEARCH (2007)
Fibroblasts and myofibroblasts: Their source, function and role in disease
Robin J. McAnulty
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Quality of life of patients with keloid and hypertrophic scarring
O Bock et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2006)
Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets
A. M. Gressner et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2006)
Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta 1 in cultured rat hepatic stellate cells
XJ Liu et al.
PHARMACEUTICAL RESEARCH (2006)
Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice
S Kanno et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Regulation of PDGF and its receptors in fibrotic diseases
JC Bonner
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats
MH Lee et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Cellular origins of fibroblasts: possible implications for organ fibrosis in systemic sclerosis
AE Postlethwaite et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension
H Reynaert et al.
GUT (2002)
Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits
SL Hsiu et al.
LIFE SCIENCES (2002)
Bioavailability of the flavanone naringenin and its glycosides in rats
C Felgines et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Share Paper
